NDC 57926-474 - Panacur

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
57926-474
Package NDCs from labels
57926-474-20
Manufacturer
Merck Sharp & Dohme Corp.
Effective date
2026-05-19
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
panacur ® (fenbendazole)Merck Sharp & Dohme Corp.2026-05-19PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
57926-474-20Panacur454 g in 1 JARGRANULE4546
57926-474-20Panacur1 in 1 CARTONGRANULE16

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
57926-474PANACUR (FENBENDAZOLE) GRANULE [MERCK SHARP & DOHME CORP.]52 package rows20241105_74980ef3-3f58-4cba-bd82-cc343f18390d.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
FENBENDAZOLEACTIVE INGREDIENT621BVT9M36PANACUR (FENBENDAZOLE) GRANULE [MERCK SHARP & DOHME CORP.]1
FENBENDAZOLEACTIVE MOIETY621BVT9M36PANACUR (FENBENDAZOLE) GRANULE [MERCK SHARP & DOHME CORP.]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Fenbendazole 222 MGFENBENDAZOLE 222 MGB & L Healthcare Products INC337c4554-2049-a725-e063-6394a90a66f52025-04-23WarningsExact identifier
unii: 621BVT9M36

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.